Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Liposomal Bupivacaine Versus Ropivacaine for Interscalene Brachial Plexus Block in Alleviating Rebound Pain Following Shoulder Arthroscopy

NCT07196631 is registered in ClinicalTrials.gov with Liu Jiuhong as lead sponsor.

NCT NCT07196631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07196631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Liposomal Bupivacaine Versus Ropivacaine for Interscalene Brachial Plexus Block in Alleviating Rebound Pain Following Shoulder Arthroscopy
Lead sponsor
Liu Jiuhong
Phase
Phase 4
Overall status
Completed
Start date
September 20, 2025
Completion date
January 2, 2026
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liposomal bupivacaine, rebound pain